Pfizer Looks to Europe For Coronavirus Vaccine
Pfizer Looks to Europe For Coronavirus Vaccine
GALWAY, IRELAND--March 24, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pharmaceutical heavyweight Pfizer (NYSE:PFE) (New York, New York) has become the latest company to sign a deal with Germany's BioNTech SE to co-develop a potential vaccine for the coronavirus.
Within this article: Details alliance to fast-track coronavirus vaccine, similar deals with Chinese company, impact of virus on people and industry
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- México registra inversiones por 2 mil millones de dólares en el sector farm...
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market